Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia [4]

Bone Marrow Transplantation

Volumn 34, Issue 2, 2004, Pages 189-191

  Athanasiadou, A ^a   Stamatopoulos, K ^a   Sakellari, I ^a   Zorbas, I ^a   Gaitatzi, M ^a   Fassas, A ^a   Anagnostopoulos, A ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; BUSULFAN; CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; DNA; DOXORUBICIN; ETOPOSIDE; HLA ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; MINOR HISTOCOMPATIBILITY ANTIGEN; MYELOPEROXIDASE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; DNA DETERMINATION; DONOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GRAFT VERSUS HOST REACTION; HETEROZYGOSITY; HLA MATCHING; HOMOZYGOSITY; HUMAN; KARYOTYPE; LETTER; PATIENT REFERRAL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SEGREGATION ANALYSIS; SIBLING; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; FEMALE; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; NEOPLASMS, SECOND PRIMARY; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 4043159893     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704554     Document Type: Letter

References (8)

1. Cooley LD, Sears DA, Udden MM et al. Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol 2002; 63: 46-53.
2. Boyd CN, Ramberg RC, Thomas ED. The incidence of recurrence of leukaemia in donor cells after allogeneic bone marrow transplantation. Leuk Res 1982; 6: 833-837.
3. Saito Y, Uzuka Y, Sakai N et al. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Bone Marrow Transplant 2000; 25: 1209-1211.
4. Gopcsa L, Barta A, Banyai A et al. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 2002; 29: 449-452.
5. McCann SR, Lawler M, Gardiner N, O'Riordan J. Donor leukemia following allogeneic bone marrow transplantation. Leukemia 1994; 8: S133-S135.
6. Spinelli O, Giussani U, Borleri G et al. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation. Haematologica 2000; 85: 1153-1157.
7. Jolkowska J, Wachowiak J, Lange A et al. Molecular assessment of post-BMT chimerism using various biologic specimens and automated DNA sizing technology. J Hematother Stem Cell Res 2000; 9: 263-268.
8. Pierce RA, Field ED, Mutis T et al. The HA-2minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol 2001; 167: 3223-3230.